Back in the early 1990s a Scottish salmon farmer told Elliot Entis, founder and CEO of fledgling GM salmon producer AquaBounty, that it would take 10 years before the fish would make it to market.
"I said, no, we'll do it much faster than that," Entis told IntraFish Monday.
Though he was well off in his optimistic projections, Entis is celebrating the long-awaited decision by the US Food and Drug Administration (FDA) last Friday to lift an import restriction that has been preventing Massachusetts-based AquaBounty from producing and selling its genetically modified fish in the United States.
